DRL Announces The Launch Of Anti-Allergy Drug In US Market
Dr. Reddy’s Laboratories Ltd. (DRL) has announced that it has launched Levocetirizine Dihydrochloride Tablets USP, 5 mg, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy 24HR Tablets, from UCB, in the US market as approved by the US FDA. The drug is an over-the-counter antihistamine used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing.
“This first-to-market launch for the store brand is the testament to the deep capabilities of our store brand OTC business,” said Mr. Milan Kalawadia, Vice President and Head, US Over-the-Counter and Speciality Rx businesses, DRL.
The Xyzal Allergy 24HR Tablets brand had US sales of approximately $71-mn for the most recent twelve months ending in January 2018.
2026-08-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The United States Lifts Restrictions on Ethane Exports to China, and Trade Relations Show Signs of Easing
-
Biden decided to raise tariffs on Chinese goods, US soybeans maybe face tariff adjustment challenges
-
U.S. agricultural supplies distributor CHS and West Central Ag Services sign merger intent
-
PPG launches strategic review: intends to sell North American architectural coatings business with annual revenue of nearly US$1.8 billion
-
The US chemical industry has had a tough profit season
-
Warm winter impact energy market US coal prices fell rapidly
-
The United States has released its annual update on Salmonella surveillance and testing at poultry producers across the country
-
Allergic rhinitis is back! Experts remind: early prevention and standardized treatment
-
How to Prevent Allergies?
-
Allergics? What Foods to Eat to Prevent Skin Allergies
Recommend Reading
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
US Imposes Heavy Duties on Chinese L-Lysine with Combined Rates up to 188%
-
India Imposes Anti-Dumping Duties on Rubber Chemicals from China, EU and U.S.
-
Venezuela’s Moron Petrochemical Complex Restarts as Regional Supply Risks Remain
-
Urea Market Lacks Direction as China, Iran Supply and India Tender Shape Outlook
-
Weak Supply and Demand in the Off-Season, Polyethylene Continues to Decline in June
-
This Week's Isopropanol Market Prices Slightly Increased in China (8.10-8.14)
-
Price Increase Announcements Concentrated, Chinese Polymeric MDI Market Pushes for Rise
-
Cost Values Collapse Significant PP Price Decrease in China in June
-
BDO Market Conditions Consolidating and in a Wait-and-See Mode